Chugai Pharmaceutical Co., Ltd. (CHGCY)

Total Valuation

CHGCY has a market cap or net worth of 68.01 billion. The enterprise value is 61.04 billion.

Market Cap	68.01B
Enterprise Value	61.04B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Dec 29, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	639.77M

Valuation Ratios

The trailing PE ratio is 24.81.

PE Ratio	24.81
Forward PE	n/a
PS Ratio	8.20
PB Ratio	4.94
P/TBV Ratio	5.03
P/FCF Ratio	24.82
P/OCF Ratio	21.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.28, with an EV/FCF ratio of 22.27.

EV / Earnings	22.27
EV / Sales	7.52
EV / EBITDA	15.28
EV / EBIT	16.15
EV / FCF	22.27

Financial Position

The company has a current ratio of 6.04

Current Ratio	6.04
Quick Ratio	5.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	10,317.56

Financial Efficiency

Return on equity (ROE) is 21.16% and return on invested capital (ROIC) is 18.64%.

Return on Equity (ROE)	21.16%
Return on Assets (ROA)	16.05%
Return on Invested Capital (ROIC)	18.64%
Return on Capital Employed (ROCE)	27.72%
Revenue Per Employee	1.65M
Profits Per Employee	545,341
Employee Count	5,026
Asset Turnover	0.55
Inventory Turnover	1.41

Taxes

In the past 12 months, CHGCY has paid 1.11 billion in taxes.

Income Tax	1.11B
Effective Tax Rate	28.90%

Stock Price Statistics

The stock price has decreased by -2.72% in the last 52 weeks. The beta is 0.69, so CHGCY's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-2.72%
50-Day Moving Average	24.87
200-Day Moving Average	23.92
Relative Strength Index (RSI)	27.26
Average Volume (20 Days)	330,113

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CHGCY had revenue of 8.29 billion and earned 2.74 billion in profits. Earnings per share was 1.67.

Revenue	8.29B
Gross Profit	5.83B
Operating Income	3.86B
Pretax Income	3.85B
Net Income	2.74B
EBITDA	4.04B
EBIT	3.86B
Earnings Per Share (EPS)	1.67

Balance Sheet

The company has 7.12 billion in cash and n/a in debt, giving a net cash position of 7.12 billion.

Cash & Cash Equivalents	7.12B
Total Debt	n/a
Net Cash	7.12B
Net Cash Per Share	n/a
Equity (Book Value)	13.76B
Book Value Per Share	8.36
Working Capital	9.37B

Cash Flow

In the last 12 months, operating cash flow was 3.20 billion and capital expenditures -462.76 million, giving a free cash flow of 2.74 billion.

Operating Cash Flow	3.20B
Capital Expenditures	-462.76M
Free Cash Flow	2.74B
FCF Per Share	n/a

Margins

Gross margin is 70.37%, with operating and profit margins of 46.58% and 33.06%.

Gross Margin	70.37%
Operating Margin	46.58%
Pretax Margin	46.49%
Profit Margin	33.06%
EBITDA Margin	48.78%
EBIT Margin	46.58%
FCF Margin	33.05%

Dividends & Yields

This stock pays an annual dividend of 1.71, which amounts to a dividend yield of 6.83%.

Dividend Per Share	1.71
Dividend Yield	6.83%
Dividend Growth (YoY)	177.36%
Years of Dividend Growth	1
Payout Ratio	40.86%
Buyback Yield	-0.01%
Shareholder Yield	6.83%
Earnings Yield	4.03%
FCF Yield	4.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.

Last Split Date	Jul 6, 2020
Split Type	Forward
Split Ratio	12

Scores

CHGCY has an Altman Z-Score of 26.68 and a Piotroski F-Score of 6.

Altman Z-Score	26.68
Piotroski F-Score	6